The page could not be loaded. The CMS.gov Web site currently does not fully support browsers with
Ambulatory blood pressure monitoring (ABPM) is a non-invasive diagnostic test that uses a device to determine blood pressure over 24-hour cycles. In this way, blood pressure can be measured over time rather than discrete measurements that are usually obtained. These measurements are stored in the device and later interpreted.
Section 20.19 of the Medicare National Coverage Determination (NCD) Manual states the conditions of coverage for ABPM. CMS determined in 2001 that ABPM is covered only for those patients with suspected white coat hypertension, which is defined as: 1) office blood pressure >140/90 mm Hg on at least three separate clinic/office visits with two separate measurements made at each visit; 2) at least two documented blood pressure measurements taken outside the office which are < 140/90 mm Hg; and 3) no evidence of end-organ damage. ABPM is not covered for other uses.
CMS is soliciting public comment relevant to the request. We are particularly interested in comments that include scientific evidence and that address the breadth of the request
October 9, 2018
CMS initiates this national coverage analysis for Ambulatory Blood Pressure Monitoring. The initial 30-day public comment period begins with this posting date, and ends after 30 calendar days. CMS considers all public comments, and is particularly interested in clinical studies and other scientific information relevant to the topic under review.
Instructions on submitting comments can be found at:
To submit a comment, please use the orange "Comment" button at the top of the page. Enter comments directly into the "Submit A Public Comment" webpage.
April 9, 2019
July 2, 2019